Anand Sharma
Affiliations: | 2013-2016 | University of Oxford, Oxford, United Kingdom |
Google:
"Anand Sharma"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Omorphos NP, Ghose A, Hayes JDB, et al. (2022) The increasing indications of FDG-PET/CT in the staging and management of Invasive Bladder Cancer. Urologic Oncology |
Sharma A, Vasdev N. (2019) Does neuroendocrine like tumor pathology impact neoadjuvant chemotherapy response precystectomy. Urologic Oncology |
Shamash J, Syed R, Sarker SJ, et al. (2019) A phase II study of carboplatin AUC-10 guided by positron emission tomography-defined metabolic response in metastatic seminoma. European Journal of Cancer (Oxford, England : 1990). 115: 128-135 |
Kocher MR, Sharma A, Garrett-Mayer E, et al. (2017) Pretreatment 18F-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Values and Tumor Size in Medically Inoperable Nonsmall Cell Lung Cancer Is Prognostic of Overall 2-Year Survival After Stereotactic Body Radiation Therapy. Journal of Computer Assisted Tomography |
Pastis NJ, Greer TJ, Tanner NT, et al. (2014) Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Chest. 146: 406-11 |
Pchejetski D, Nunes J, Sauer L, et al. (2010) Circulating sphingosine-1-phosphate inversely correlates with chemotherapy-induced weight gain during early breast cancer. Breast Cancer Research and Treatment. 124: 543-9 |
Sharma A, Ngan S, Nandoskar A, et al. (2010) Schizophrenia does not adversely affect the treatment of women with breast cancer: a cohort study. Breast (Edinburgh, Scotland). 19: 410-2 |
Sharma A, Crook T, Thompson A, et al. (2010) Surgical oncology: why biopsying metastatic breast cancer should be routine. Nature Reviews. Clinical Oncology. 7: 72-4 |